目的:探讨2型糖尿病患者血清趋化素(chemerin)、非高密度脂蛋白胆固醇和高密度脂蛋白胆固醇比值(non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio,non-HDL-C/HDL-C)与微量白蛋白尿的相关性。方...目的:探讨2型糖尿病患者血清趋化素(chemerin)、非高密度脂蛋白胆固醇和高密度脂蛋白胆固醇比值(non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio,non-HDL-C/HDL-C)与微量白蛋白尿的相关性。方法:选择2型糖尿病患者共254例,按照尿白蛋白/肌酐比率(urinary albumin to creatinine ratio,UACR)分为正常白蛋白尿组(UACR<30μg/mg,129例)和微量白蛋白尿组(UACR 30~<300μg/mg,125例)。采用酶联免疫吸附试验法检测血清chemerin水平,同时记录糖尿病病程、身高、体重、腰围等临床一般资料,测定血脂、空腹血糖、空腹胰岛素、糖化血红蛋白等生化指标。结果:微量白蛋白尿组的病程、腰围、血清chemerin、non-HDL-C、non-HDL-C/HDL-C、糖化血红蛋白、胰岛素抵抗指数均高于正常白蛋白尿组,差异均有统计学意义(P<0.05);Pearson相关分析显示UACR与病程、腰围、血清chemerin、non-HDL-C、non-HDL-C/HDL-C、糖化血红蛋白、胰岛素抵抗指数均呈正相关(P<0.05);以微量白蛋白尿为因变量的二分类非条件Logistic回归分析结果显示血清chemerin、non-HDL-C/HDL-C作为独立影响因素影响2型糖尿病患者微量白蛋白尿的发生。结论:2型糖尿病患者血清chemerin、non-HDL-C/HDL-C与UACR呈正相关,且均为发生微量白蛋白尿的独立危险因素,两者可作为预测早期糖尿病肾病的重要参考指标。展开更多
High density lipoprotein protects cardiovascular diseases and reduces the risk of cardiovascular diseases through cholesterol reverse transport and other mechanisms. High-density lipoprotein cholesterol (HDL-C) is an ...High density lipoprotein protects cardiovascular diseases and reduces the risk of cardiovascular diseases through cholesterol reverse transport and other mechanisms. High-density lipoprotein cholesterol (HDL-C) is an independent predictor of negative events in cardiovascular diseases. Low concentration of HDL-C indicates abnormal regulation of HDL anabolism. Various proteins and receptors such as cholesteryl ester transfer protein (CETP) are involved in HDL anabolism. Type 2 Diabetes Mullitu and its related metabolic syndrome, chronic inflammation as well as oxidative stress not only affect the proteins and receptors related to HDL anabolism, but also affect their functional changes, making HDL change from anti-inflammatory, antioxidant, protecting endothelial cell function to pro-inflammatory, pro-oxidative and pro-endothelial cell apoptosis. This article will describe the relationship between HDL-C, type 2 diabetes and cardiovascular diseases from the effects of T2DM on HDL anabolism and function, and further explore the effectiveness of elevating HDL-C in treating cardiovascular diseases of patients with type 2 diabetes.展开更多
Objective: The objective is to assess the relationship of Log (TG)/HDL-c as surrogate estimate of atherogenic dyslipidemia with urinary albumin excretion rate and cardiovascular risk among black patients with type 2 d...Objective: The objective is to assess the relationship of Log (TG)/HDL-c as surrogate estimate of atherogenic dyslipidemia with urinary albumin excretion rate and cardiovascular risk among black patients with type 2 diabetes. Patients and methods: A post-hoc analysis of data from 181 type 2 diabetes patients enrolled in a cross-sectional study of urinary albumin excretion rate seen at a tertiary healthcare. Microalbuminuria and macroalbuminuria were defined as ACR 30 - 299.9 mg/g and ACR ≥ 300 mg/g, respectively. Quartiles of Log (TG)/HDL-c were used as surrogate estimates of atherogenic dyslipidemia. Cardiovascular risk was assessed using WHO chart for estimation of CV risk in low and middle income countries. Comparisons across Log (TG)/HDL-c quartiles were performed using one way ANOVA and Chi square for trend as appropriate. P < 0.05 defined the level of statistical significance. Results: A high prevalence (69%) of atherogenic dyslipidemia (AD) was observed in the present case series of Black Africans with type 2 diabetes. Average total cholesterol levels showed significant (p = 0.010) trends towards lower values across quartiles of Log (TG)/ HDL-c. No significant trends were observed for average UAER and cardiovascular risk across quartiles of Log (TG)/HDL-c. Conclusion: Log (TG)/HDL-c as a surrogate estimate of atherogenic failed to predict cardiovascular risk in the present case series of black patients with type 2 diabetes.展开更多
目的 探讨运脾方联合穴位贴敷对2型糖尿病一级亲属中非糖尿病者的胰岛功能及非高密度脂蛋白/高密度脂蛋白(NHDL-C/HDL-C)、载脂蛋白B/载脂蛋白A-1(ApoB/ApoA-1)的影响。方法 该研究前瞻性选取2019年1月—2020年1月河北省中医院内分泌科...目的 探讨运脾方联合穴位贴敷对2型糖尿病一级亲属中非糖尿病者的胰岛功能及非高密度脂蛋白/高密度脂蛋白(NHDL-C/HDL-C)、载脂蛋白B/载脂蛋白A-1(ApoB/ApoA-1)的影响。方法 该研究前瞻性选取2019年1月—2020年1月河北省中医院内分泌科门诊及住院的2型糖尿病一级亲属中非糖尿病者119例为本次研究对象,采用随机对照的方法分为观察组及对照组。对照组60例患者予以个体化的健康教育,观察组59例患者则在运脾方的基础上加以联合应用穴位贴敷进行治疗,于入组前后分别检测两组患者的血糖及胰岛功能、血压、血脂、血尿酸指标,同时记录体质量、腰围、身体体质量指数(BMI)指数指标,并对NHDL-C/HDL-C、ApoB/ApoA-I指标予以检测分析。结果 干预后两组患者的血糖、C肽以及胰岛素较干预前均有了显著改善,且干预后观察组患者的空腹血糖(FPG)、负荷后1 h血糖(1 hPG)、负荷后2 h血糖(2 hPG)、空腹C肽(FCP)、负荷后1 h C肽(1 h CP)、负荷后2 h C肽(2 h CP)、空腹胰岛素(FIns)、负荷后1 h胰岛素(1 h Ins)及负荷后2 h胰岛素(2 hIns)指标均显著低于对照组(P<0.05);同时,干预后两组患者的胰岛素抵抗指数(HOMA-IR)较干预前也有了显著改善,且干预后观察组患者的HOMA-IR显著低于对照组(P<0.05);干预后两组患者的血脂、血尿酸水平较干预前均有了显著改善,且干预后观察组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)以及血尿酸(UA)水平明显比对照组低,而高密度脂蛋白胆固醇(HDL-C)水平则比对照组高(P<0.05);干预后两组患者的收缩期血压(SBP)、收缩期血压(DBP)、BMI以及腰臀比指数(WHR)水平较干预前有了明显改善,且干预后观察组患者的SBP、DBP、BMI以及WHR水平显著优于对照组(P<0.05);干预后两组患者NHDL-C/HDL-C、ApoB/ApoA-1水平较干预前均显著降低(P<0.05),且干预后观察组NHDL-C/HDL-C、ApoB/ApoA-1水平均显著低于对照组(P<0.05)。结论 通过运脾方联合穴位贴敷治疗2型糖尿病一级亲属中非糖尿病者,可有效降低患者的血糖、血脂及血尿酸水平,改善胰岛功能和NHDL-C/HDL-C、ApoB/ApoA-1水平,进而有效预防糖尿病的发生,值得推广。展开更多
文摘目的:探讨2型糖尿病患者血清趋化素(chemerin)、非高密度脂蛋白胆固醇和高密度脂蛋白胆固醇比值(non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio,non-HDL-C/HDL-C)与微量白蛋白尿的相关性。方法:选择2型糖尿病患者共254例,按照尿白蛋白/肌酐比率(urinary albumin to creatinine ratio,UACR)分为正常白蛋白尿组(UACR<30μg/mg,129例)和微量白蛋白尿组(UACR 30~<300μg/mg,125例)。采用酶联免疫吸附试验法检测血清chemerin水平,同时记录糖尿病病程、身高、体重、腰围等临床一般资料,测定血脂、空腹血糖、空腹胰岛素、糖化血红蛋白等生化指标。结果:微量白蛋白尿组的病程、腰围、血清chemerin、non-HDL-C、non-HDL-C/HDL-C、糖化血红蛋白、胰岛素抵抗指数均高于正常白蛋白尿组,差异均有统计学意义(P<0.05);Pearson相关分析显示UACR与病程、腰围、血清chemerin、non-HDL-C、non-HDL-C/HDL-C、糖化血红蛋白、胰岛素抵抗指数均呈正相关(P<0.05);以微量白蛋白尿为因变量的二分类非条件Logistic回归分析结果显示血清chemerin、non-HDL-C/HDL-C作为独立影响因素影响2型糖尿病患者微量白蛋白尿的发生。结论:2型糖尿病患者血清chemerin、non-HDL-C/HDL-C与UACR呈正相关,且均为发生微量白蛋白尿的独立危险因素,两者可作为预测早期糖尿病肾病的重要参考指标。
文摘High density lipoprotein protects cardiovascular diseases and reduces the risk of cardiovascular diseases through cholesterol reverse transport and other mechanisms. High-density lipoprotein cholesterol (HDL-C) is an independent predictor of negative events in cardiovascular diseases. Low concentration of HDL-C indicates abnormal regulation of HDL anabolism. Various proteins and receptors such as cholesteryl ester transfer protein (CETP) are involved in HDL anabolism. Type 2 Diabetes Mullitu and its related metabolic syndrome, chronic inflammation as well as oxidative stress not only affect the proteins and receptors related to HDL anabolism, but also affect their functional changes, making HDL change from anti-inflammatory, antioxidant, protecting endothelial cell function to pro-inflammatory, pro-oxidative and pro-endothelial cell apoptosis. This article will describe the relationship between HDL-C, type 2 diabetes and cardiovascular diseases from the effects of T2DM on HDL anabolism and function, and further explore the effectiveness of elevating HDL-C in treating cardiovascular diseases of patients with type 2 diabetes.
文摘Objective: The objective is to assess the relationship of Log (TG)/HDL-c as surrogate estimate of atherogenic dyslipidemia with urinary albumin excretion rate and cardiovascular risk among black patients with type 2 diabetes. Patients and methods: A post-hoc analysis of data from 181 type 2 diabetes patients enrolled in a cross-sectional study of urinary albumin excretion rate seen at a tertiary healthcare. Microalbuminuria and macroalbuminuria were defined as ACR 30 - 299.9 mg/g and ACR ≥ 300 mg/g, respectively. Quartiles of Log (TG)/HDL-c were used as surrogate estimates of atherogenic dyslipidemia. Cardiovascular risk was assessed using WHO chart for estimation of CV risk in low and middle income countries. Comparisons across Log (TG)/HDL-c quartiles were performed using one way ANOVA and Chi square for trend as appropriate. P < 0.05 defined the level of statistical significance. Results: A high prevalence (69%) of atherogenic dyslipidemia (AD) was observed in the present case series of Black Africans with type 2 diabetes. Average total cholesterol levels showed significant (p = 0.010) trends towards lower values across quartiles of Log (TG)/ HDL-c. No significant trends were observed for average UAER and cardiovascular risk across quartiles of Log (TG)/HDL-c. Conclusion: Log (TG)/HDL-c as a surrogate estimate of atherogenic failed to predict cardiovascular risk in the present case series of black patients with type 2 diabetes.
文摘目的 探讨运脾方联合穴位贴敷对2型糖尿病一级亲属中非糖尿病者的胰岛功能及非高密度脂蛋白/高密度脂蛋白(NHDL-C/HDL-C)、载脂蛋白B/载脂蛋白A-1(ApoB/ApoA-1)的影响。方法 该研究前瞻性选取2019年1月—2020年1月河北省中医院内分泌科门诊及住院的2型糖尿病一级亲属中非糖尿病者119例为本次研究对象,采用随机对照的方法分为观察组及对照组。对照组60例患者予以个体化的健康教育,观察组59例患者则在运脾方的基础上加以联合应用穴位贴敷进行治疗,于入组前后分别检测两组患者的血糖及胰岛功能、血压、血脂、血尿酸指标,同时记录体质量、腰围、身体体质量指数(BMI)指数指标,并对NHDL-C/HDL-C、ApoB/ApoA-I指标予以检测分析。结果 干预后两组患者的血糖、C肽以及胰岛素较干预前均有了显著改善,且干预后观察组患者的空腹血糖(FPG)、负荷后1 h血糖(1 hPG)、负荷后2 h血糖(2 hPG)、空腹C肽(FCP)、负荷后1 h C肽(1 h CP)、负荷后2 h C肽(2 h CP)、空腹胰岛素(FIns)、负荷后1 h胰岛素(1 h Ins)及负荷后2 h胰岛素(2 hIns)指标均显著低于对照组(P<0.05);同时,干预后两组患者的胰岛素抵抗指数(HOMA-IR)较干预前也有了显著改善,且干预后观察组患者的HOMA-IR显著低于对照组(P<0.05);干预后两组患者的血脂、血尿酸水平较干预前均有了显著改善,且干预后观察组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)以及血尿酸(UA)水平明显比对照组低,而高密度脂蛋白胆固醇(HDL-C)水平则比对照组高(P<0.05);干预后两组患者的收缩期血压(SBP)、收缩期血压(DBP)、BMI以及腰臀比指数(WHR)水平较干预前有了明显改善,且干预后观察组患者的SBP、DBP、BMI以及WHR水平显著优于对照组(P<0.05);干预后两组患者NHDL-C/HDL-C、ApoB/ApoA-1水平较干预前均显著降低(P<0.05),且干预后观察组NHDL-C/HDL-C、ApoB/ApoA-1水平均显著低于对照组(P<0.05)。结论 通过运脾方联合穴位贴敷治疗2型糖尿病一级亲属中非糖尿病者,可有效降低患者的血糖、血脂及血尿酸水平,改善胰岛功能和NHDL-C/HDL-C、ApoB/ApoA-1水平,进而有效预防糖尿病的发生,值得推广。